Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Winter 2010 - Plasma
Download Issue
Share
Up Front
Publisher's Corner
Patients First
By Patrick M. Schmidt
Features
IVIG: At the Intersection of Immunology and Clinical Research
By
Keith Berman, MPH, MBA
Better by Design: New Coagulation Products on the Horizon
By
Keith Berman, MPH, MBA
A Comparative Look at IVIG and SCIG
By
Show No Author
Myths and Facts: Meningitis
By
Ronale Tucker Rhodes, MS
Plasma Therapies: IG in the Driver’s Seat
By
Show No Author
BioTrends Watch
Washington Report
Healthcare Reform Issues for Chronic and Rare Issues
Alliance Receives Nonprofit Status
Medicare Part D Drug Plan Premiums Rise
Industry News
CDC Says Most U.S. Teens Get Vaccinated
Octapharma Applies to FDA for New IVIG Drug
Hemophiliacs Eligible for College Scholarships
Flu-Free Mom Receives Excellence Award
Pneumonia Vaccine Could Prevent Flu Deaths
FDA Approves Novartis' New Seasonal Flu Vaccine
Merck Now Exclusive Distributor of Afluria
Companies Struggle to Improve Healthcare Industry Supply Chain
BioFocus
Industry Insight
Scientists Flying the Coop on Flu Vaccine Manufacturing
By Ronale Tucker Rhodes, MS
BioSources